1. Home
  2. BLTE vs BL Comparison

BLTE vs BL Comparison

Compare BLTE & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • BL
  • Stock Information
  • Founded
  • BLTE 2018
  • BL 2001
  • Country
  • BLTE United States
  • BL United States
  • Employees
  • BLTE N/A
  • BL N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • BL Computer Software: Prepackaged Software
  • Sector
  • BLTE Health Care
  • BL Technology
  • Exchange
  • BLTE Nasdaq
  • BL Nasdaq
  • Market Cap
  • BLTE 4.1B
  • BL 3.3B
  • IPO Year
  • BLTE 2022
  • BL 2016
  • Fundamental
  • Price
  • BLTE $124.75
  • BL $54.73
  • Analyst Decision
  • BLTE Strong Buy
  • BL Buy
  • Analyst Count
  • BLTE 5
  • BL 12
  • Target Price
  • BLTE $105.00
  • BL $59.33
  • AVG Volume (30 Days)
  • BLTE 96.5K
  • BL 1.3M
  • Earning Date
  • BLTE 11-10-2025
  • BL 11-06-2025
  • Dividend Yield
  • BLTE N/A
  • BL N/A
  • EPS Growth
  • BLTE N/A
  • BL 20.46
  • EPS
  • BLTE N/A
  • BL 1.18
  • Revenue
  • BLTE N/A
  • BL $686,706,000.00
  • Revenue This Year
  • BLTE N/A
  • BL $10.43
  • Revenue Next Year
  • BLTE N/A
  • BL $8.73
  • P/E Ratio
  • BLTE N/A
  • BL $46.33
  • Revenue Growth
  • BLTE N/A
  • BL 7.36
  • 52 Week Low
  • BLTE $49.00
  • BL $40.82
  • 52 Week High
  • BLTE $125.01
  • BL $66.25
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 75.17
  • BL 50.76
  • Support Level
  • BLTE $108.75
  • BL $50.70
  • Resistance Level
  • BLTE $124.73
  • BL $56.72
  • Average True Range (ATR)
  • BLTE 7.56
  • BL 1.98
  • MACD
  • BLTE 0.44
  • BL -0.31
  • Stochastic Oscillator
  • BLTE 96.99
  • BL 46.94

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About BL BlackLine Inc.

BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.

Share on Social Networks: